Citations 2
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Barth, Matthew J. , Audino, Anthony , Blazin, Lindsay , Chung, Jong , Davies, Kimberly, Ding, Hilda, Ford, James B. , Galardy, Paul J. , Hanna, Rabi , Hayashi, Robert J. , Lee‐Miller, Cathy , Machnitz, Andrea Judit, Maloney, Kelly W. , Marks, Lianna J. , Martin, Paul L. , Pacheco, Martha, Reilly, Anne F. , Roshal, Mikhail , Song, Sophie X. , Weinstein, Joanna , Zarnegar‐Lumley, Sara , McMillian, Nicole R., Schonfeld, Ryan, Sundar, Hema, Blazin, Lindsay J , Xavier, Ana C , Armenian, Saro H. , Bloom, David E. , McCall, David C.
Journal of the National Comprehensive Cancer Network | November 9, 2022 | Volume: 20 | Issue: 11 | Pages: 1267-1275
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.
Pediatric Hodgkin Lymphoma, Version 3.2021
Hiniker, Susan M. , Benya, Ellen C. , Bobbey, Adam J. , Cooper, Stacy , Cuglievan, Branko , Isenalumhe, Leidy , Kelly, Kara M. , Kersun, Leslie S. , Lamble, Adam J. , Larrier, Nicole, Magee, J.Fergall, Oduro, Kwadwo A. , Pacheco, Martha, Roberts, Kenneth B. , Smith, Christine M. , Sohani, Aliyah R. , Trovillion, Erin , Walling, Emily , Burns, Jennifer L. , Campbell, Mallory, Smith, Christine M , Flerlage, Jamie E. , Armenian, Saro H. , Chang, Vivian Y. , Coulter, Donald W. , Hoppe, Bradford S. , Magee, Jeffrey, Price, Anita P. , Xavier, Ana C
Journal of the National Comprehensive Cancer Network | November 24, 2021 | Volume: 19 | Issue: 6 | Pages: 733-754
Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.